← Browse by Condition
Medical Condition

open label

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 1
NCT05929235 Phase 1
Recruiting

A Study of FX-909 in Patients With Advanced Solid Malignancies, Including Advanced Urothelial Carcinoma

Enrollment
120 pts
Location
United States
Sponsor
Flare Therapeutics Inc.
View Trial →